E-ISSN 2218-6050 | ISSN 2226-4485
 
2025, Vol: 15, Issue: 4
15 / 4Current Issue ArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

OVJ Manuscript Submissio Form

Original Article


Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker

Alice Savarese, Monica Probo, Chiara Locatelli, Sergio Aurelio Zanzani, Alessia Libera Gazzonis, Melissa Papa, Paola Giuseppina Brambilla.


Cited By:20

Abstract
The most common cause of heart failure in the canine population is myxomatous mitral valve disease, sometimes complicated by chronic kidney disease.
Many studies have been done on the use of symmetric dimethylarginine as biomarker of renal impairment in dogs affected by chronic kidney disease, few studies have examined his reliability as biomarker in dogs affected by heart diseases. Aim of this study was to evaluate symmetric dimethylarginine in dogs affected by mitral valve disease in order to identify early renal disorder.
This was a retrospective case-control study on a clinical population of dogs affected by mitral valve disease (cases) vs healthy dogs (controls). Both groups underwent a complete physical evaluation, echocardiographic examination, complete blood count, biochemical panel, including serum creatinine and urea and, when possible, urine analysis with protein-to-creatinine ratio. Serum was frozen and sent to IDEXX laboratories for symmetric dimethylarginine determination. General linear model was applied to data.
48 cases and 18 controls were included. Symmetric dimethylarginine value was in the reference value in the 65% (n=31) of cases, and in the 50% of controls. Once set symmetric dimethylarginine as dependent variable, no statistical significant differences were found for each variable considered (breed, age, sex, weight, class of cardiomyopathy, presence/absence of the valvular disease, presence/absence of congestive heart failure, pharmacological therapy, creatinine and urea concentration). Blood concentration of SDMA resulted not influenced by the variables mentioned above, and it could be considered a reliable marker of early renal impairment in dogs affected by mitral valve disease.

Key words: Symmetric dimethylarginine (SDMA), myxomatous mitral valve disease (MMVD), cardiovascular-renal disorder, dog, biomarker.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Alice Savarese
Articles by Monica Probo
Articles by Chiara Locatelli
Articles by Sergio Aurelio Zanzani
Articles by Alessia Libera Gazzonis
Articles by Melissa Papa
Articles by Paola Giuseppina Brambilla
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Savarese A, Probo M, Locatelli C, Zanzani SA, Gazzonis AL, Papa M, Brambilla PG. Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. Open Vet J. 2018; 8(3): 318-324. doi:10.4314/ovj.v8i3.11

Web Style

Savarese A, Probo M, Locatelli C, Zanzani SA, Gazzonis AL, Papa M, Brambilla PG. Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. https://www.openveterinaryjournal.com/?mno=291861 [Access: May 09, 2025]. doi:10.4314/ovj.v8i3.11

AMA (American Medical Association) Style

Savarese A, Probo M, Locatelli C, Zanzani SA, Gazzonis AL, Papa M, Brambilla PG. Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. Open Vet J. 2018; 8(3): 318-324. doi:10.4314/ovj.v8i3.11


Vancouver/ICMJE Style

Savarese A, Probo M, Locatelli C, Zanzani SA, Gazzonis AL, Papa M, Brambilla PG. Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. Open Vet J. (2018), [cited May 09, 2025]; 8(3): 318-324. doi:10.4314/ovj.v8i3.11


Harvard Style

Savarese, A., Probo, . M., Locatelli, . C., Zanzani, . S. A., Gazzonis, . A. L., Papa, . M. & Brambilla, . P. G. (2018) Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. Open Vet J, 8 (3), 318-324. doi:10.4314/ovj.v8i3.11


Turabian Style

Savarese, Alice, Monica Probo, Chiara Locatelli, Sergio Aurelio Zanzani, Alessia Libera Gazzonis, Melissa Papa, and Paola Giuseppina Brambilla. 2018. Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. Open Veterinary Journal, 8 (3), 318-324. doi:10.4314/ovj.v8i3.11


Chicago Style

Savarese, Alice, Monica Probo, Chiara Locatelli, Sergio Aurelio Zanzani, Alessia Libera Gazzonis, Melissa Papa, and Paola Giuseppina Brambilla. "Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker." Open Veterinary Journal 8 (2018), 318-324. doi:10.4314/ovj.v8i3.11


MLA (The Modern Language Association) Style

Savarese, Alice, Monica Probo, Chiara Locatelli, Sergio Aurelio Zanzani, Alessia Libera Gazzonis, Melissa Papa, and Paola Giuseppina Brambilla. "Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker." Open Veterinary Journal 8.3 (2018), 318-324. Print. doi:10.4314/ovj.v8i3.11


APA (American Psychological Association) Style

Savarese, A., Probo, . M., Locatelli, . C., Zanzani, . S. A., Gazzonis, . A. L., Papa, . M. & Brambilla, . P. G. (2018) Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker. Open Veterinary Journal, 8 (3), 318-324. doi:10.4314/ovj.v8i3.11


Author LoginReviewer LoginAbout PublisherPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyTerms of UseLicense InformationCopyright Information

About Open Veterinary Journal

Open Veterinary Journal provides a fast track coupled with high quality peer review process for original research articles, review articles, short communi ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

All correspondence should be addressed to:

Prof. Ibrahim Eldaghayes: Owner, Founder and Editor-in-Chief

Open Veterinary Journal


Faculty of Veterinary Medicine, University of Tripoli

P.O. Box 13662, Tripoli, Libya

and


Eldaghayes Publisher

www.eldaghayes.com 

Email: ibrahim.eldaghayes@vetmed.edu.ly